October 2017 Diabetes

What should these pharmacists do?

Can you figure out what these prescriptions say?

Read about disrespectful patients, impenetrable stock bottles, and more pet peeves.

Read about the new Rx products featured in October.

The FDA has approved ingrezza capsules for the treatment of adults with tardive dyskinesia.

Read about the new OTC Products featured in October.

Which OTC products should these pharmacists recommend?

Fad diets, just like fashion trends, come and go, except that following these diets can have much more serious consequences than landing one on the worst-dressed list.

Can an employee engaged in a legal tussle with her employer have access to records of her own prescription transactions maintained in the state’s Prescription Drug Monitoring Program database to be used as part of the legal proceedings?

I find it interesting that many people pin the blame for the opioid crisis on pharmaceutical manufacturers, wholesalers, and distributors.

Advances in immunization technology and knowledge of diseases have led to an ongoing stream of new vaccines.

The FDA recently approved betrixaban (Bevyxxa) as an oral anticoagulant (direct inhibitor of factor Xa).

Researchers have augmented insulin’s effectiveness with several rapid and long-acting analogs and new delivery systems, such as insulin pens and insulin pumps.

The number of diabetes cases continues to soar, with the latest data showing that an estimated 30.3 million Americans have the disease.

For a number of decades now there have been groups of pharmacists blessing, embracing, or in some instances, fully advocating for pharmacists to completely disassociate themselves as professionals from the act of dispensing a medication.

The increasing incidence of diabetes is outpacing the number of health care providers skilled in caring for affected patients.

Brown bag sessions and medication therapy management provide opportunities for pharmacists to personally connect with patients.